Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of “Hold” by Analysts

Masimo Corporation (NASDAQ:MASI) has received a consensus rating of “Hold” from the eight ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $189.40.

Several analysts have recently commented on the company. Wells Fargo & Company restated an “overweight” rating and issued a $190.00 target price on shares of Masimo in a research note on Friday, December 5th. Wall Street Zen upgraded Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th. Bank of America began coverage on Masimo in a research report on Monday, November 17th. They set a “neutral” rating and a $162.00 target price on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research report on Wednesday, October 8th. Finally, BTIG Research upped their price objective on shares of Masimo from $198.00 to $200.00 and gave the stock a “buy” rating in a report on Thursday, December 4th.

Masimo Stock Performance

Shares of MASI stock opened at $138.92 on Friday. The firm has a 50 day moving average of $140.07 and a 200-day moving average of $147.22. The company has a market cap of $7.46 billion, a price-to-earnings ratio of -13.18, a price-to-earnings-growth ratio of 1.42 and a beta of 1.26. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69. Masimo has a 52 week low of $125.94 and a 52 week high of $194.88.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 EPS for the quarter. Masimo had a negative net margin of 33.20% and a positive return on equity of 33.04%. The business had revenue of $617.00 million during the quarter. Masimo has set its FY 2025 guidance at 5.620-5.790 EPS. On average, equities analysts forecast that Masimo will post 4.1 earnings per share for the current year.

Hedge Funds Weigh In On Masimo

Large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada increased its holdings in Masimo by 44.5% during the 1st quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider’s stock worth $7,311,000 after purchasing an additional 13,513 shares in the last quarter. AQR Capital Management LLC grew its holdings in Masimo by 136.5% during the first quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider’s stock worth $1,305,000 after buying an additional 4,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Masimo by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after buying an additional 66 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Masimo during the 1st quarter valued at $220,000. Finally, Jones Financial Companies Lllp lifted its stake in Masimo by 1,267.1% during the 1st quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider’s stock valued at $367,000 after acquiring an additional 2,040 shares in the last quarter. Institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.